Uranium Royalty (NASDAQ:UROY) Stock Rating Upgraded by Wall Street Zen

Uranium Royalty (NASDAQ:UROY) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday.

Several other equities research analysts have also recently issued reports on UROY. Weiss Ratings upgraded shares of Uranium Royalty from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, March 12th. Raymond James Financial reiterated a “market perform” rating on shares of Uranium Royalty in a report on Wednesday, January 14th. One analyst has rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $4.50.

Uranium Royalty Stock Performance

NASDAQ UROY opened at $3.34 on Friday. The stock’s fifty day moving average is $4.11 and its two-hundred day moving average is $3.99. The firm has a market capitalization of $489.24 million, a P/E ratio of 167.08 and a beta of 1.46. Uranium Royalty has a fifty-two week low of $1.43 and a fifty-two week high of $5.52.

Uranium Royalty (NASDAQ:UROY) last issued its earnings results on Tuesday, March 10th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.02. Uranium Royalty had a return on equity of 0.01% and a net margin of 7.70%.The business had revenue of $12.25 million during the quarter. As a group, sell-side analysts forecast that Uranium Royalty will post 0.01 EPS for the current year.

Institutional Trading of Uranium Royalty

A number of hedge funds and other institutional investors have recently modified their holdings of the business. CenterBook Partners LP raised its holdings in Uranium Royalty by 828.7% in the 4th quarter. CenterBook Partners LP now owns 4,447,408 shares of the company’s stock valued at $15,744,000 after buying an additional 3,968,521 shares during the period. Acuitas Investments LLC increased its position in shares of Uranium Royalty by 120.9% during the third quarter. Acuitas Investments LLC now owns 2,237,441 shares of the company’s stock valued at $9,621,000 after acquiring an additional 1,224,465 shares during the last quarter. Simcoe Capital LLC acquired a new stake in shares of Uranium Royalty during the fourth quarter valued at about $4,001,000. Alps Advisors Inc. raised its stake in shares of Uranium Royalty by 23.7% in the 4th quarter. Alps Advisors Inc. now owns 3,892,680 shares of the company’s stock valued at $13,780,000 after acquiring an additional 745,145 shares during the period. Finally, Vident Advisory LLC raised its stake in shares of Uranium Royalty by 47.1% in the 2nd quarter. Vident Advisory LLC now owns 1,480,151 shares of the company’s stock valued at $3,700,000 after acquiring an additional 474,030 shares during the period. 24.19% of the stock is owned by institutional investors and hedge funds.

About Uranium Royalty

Uranium Royalty Corp. is a Vancouver-based mineral rights acquisition, royalty and streaming company focused exclusively on the uranium sector. Established in early 2021 and listed on the NASDAQ under the symbol UROY, the company seeks to provide investors with leveraged exposure to uranium prices without direct mining risk. Rather than owning or operating mines, Uranium Royalty acquires long-term royalties and streams on both production and development-stage uranium projects worldwide.

The company’s diversified portfolio encompasses royalty interests across multiple jurisdictions, including Canada, the United States, South America, Central Asia and Australia.